Details

Autor(en) / Beteiligte

• Zhu, Ruizheng
• Yan, Jianna
• Li, Benshang
• Tan, Fei
• Yan, Wannian
• Shen, Juan
• Fan, Lingzhi
• Ding, Lixia
• Chen, Yuchong
• Tang, Yichen
• Liu, Yeqiang
• Bai, Yun

Titel

Determination of COL1A1–PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberans

Ist Teil von

• Experimental and molecular pathology, 2021-10, Vol.122, p.104672-104672, Article 104672

Ort / Verlag

Netherlands: Elsevier Inc

Erscheinungsjahr

2021

Link zum Volltext

Quelle

ScienceDirect

Beschreibungen/Notizen

• In most cases, dermatofibrosarcoma protuberans (DFSP) is characterized by the chromosomal translocation t (17; 22) (q22; q13) that leads to a fusion of collagen type 1 alpha 1 (COL1A1) and platelet-derived growth factor beta chain (PDGFB). Recently, next-generation sequencing (NGS) has been reported to detect fusion transcripts in some malignancies. Therefore, the present study aimed to evaluate the utility of the targeted NGS in detecting the COL1A1–PDGFB fusion in patients with DFSP. We designed a targeted DNA capture panel to tile along the fusion regions, including exon, intron, and untranslated regions of the COL1A1 and PDGFB. A cohort of 18 DNA samples extracted from formalin-fixed, paraffin-embedded tissues was used to evaluate the targeted NGS. The results were compared with that of fluorescence in situ hybridization (FISH). The COL1A1–PDGFB fusion was identified in 13 of 18 cases (72.2%) by targeted NGS assay. PDGFB breakpoints were constantly found in exon 2, while breakpoints in COL1A1 varied from exon 15 to 46. Of these 18 cases assayed by FISH, 12 (66.7%) exhibited COL1A1–PDGFB fusion signals. One case (P9), which was FISH-negative, was demonstrated with the fusion by targeted NGS and validated by PCR and Sanger sequencing. The targeted NGS results showed a high concordance with the results of the FISH assay (94.4%). Our study reported a targeted NGS assay for detecting the breakpoints of the COL1A1–PDGFB fusion gene, which can be implemented in diagnosing patients with DFSP.